GlassScriptPhysician profile
Gilbert A Leidig
NPI 1902835770
$1,462.86
in general payments reported to CMS, 2019-2025
20 companies · $55.31 in 2025
The $55.31 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $94.67 · 2021: $372 · 2022: $52.41 · 2023: $288 · 2024: $194 · 2025: $55.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $324.67 | 2021-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $257.08 | 2019-2025 | |
| Esperion Therapeutics, INC. | $146.01 | 2020-2021 | |
| Heartflow, INC. | $130.50 | 2023 | Ffrct |
| Akcea Therapeutics, INC. | $129.89 | 2019 | |
| Janssen Pharmaceuticals, INC | $95.90 | 2019-2021 | |
| Boston Scientific Corporation | $61.66 | 2019-2021 | |
| Amgen INC. | $46.34 | 2019-2021 | |
| Pfizer INC. | $36.30 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.13 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.12 | 2019-2020 | |
| Chiesi USA, INC. | $27.64 | 2019 | |
| Medtronic, INC. | $27.29 | 2025 | Ffrangio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.98 | 2022-2023 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $20.59 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $20.44 | 2021 | |
| Siemens Medical Solutions USA, INC. | $13.53 | 2025 | Syngo Dynamics, Syngo.Via |
| Amarin Pharma, INC. | $13.36 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.30 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Leidig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.